AmeriCann (OTCQX: ACAN), a medical marijuana facility developer based in Denver, Colorado, recently launched the first phase of its planned MMJ facility in Massachusetts, and retained highly-experienced Campanelli Construction as general contractor. In the first quarter of 2017, AmeriCann plans to break ground on the Massachusetts Medical Cannabis Center – which is approved for 1 million square feet – and expects to have its preferred partners start cannabis production on the property by fall. When complete, the facility will be one of the largest and most technologically-advanced medical marijuana centers in the United States. The first phase of the project could cost up to $25 million and will include a 30,000-square-foot development and research building and a 130,000-square-foot processing and cultivation facility, according to AmeriCann CEO Tim Keogh. The State of Massachusetts allows both medical and recreational marijuana use.
To learn more, visit www.americann.co
AmeriCann is a publicly traded company that plans to develop and lease sustainable, state-of-the-art medical cannabis cultivation properties. The Company has over 1,000,000 square feet of facilities in the planning and design stages of development. The Company has designed a proprietary line of cannabis infused products which will be branded and licensed to companies in regulated markets. AmeriCann, Inc. is a Certified B Corp, an acknowledgment of the company’s commitment to social and environmental ethics, transparency and accountability. AmeriCann became the first public cannabis company to earn this respected accreditation.
NetworkNewsBreak (NNB) provides a rapid summary of corporate news that caught the attention of CannabisNewsWire (CNW). NNB keeps you up-to-date on active US Public Companies complementary to CNW’s broader scope as a provider of news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As a multifaceted financial news and distribution company with an extensive team of journalists and writers, CNW is uniquely positioned to best serve private and public companies who need to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.
For more information, visit https://www.cannabisnewswire.com.
Please see full disclaimers on the CannabisNewsWire website: http://nnw.fm/Disclaimer